UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
February 13, 2019
ORDER GRANTING CONFIDENTIAL TREATMENT UNDER THE SECURITIES EXCHANGE ACT OF 1934
NxStage Medical, Inc.
File No. 000-51567 - CF#37133 _____________________
NxStage Medical, Inc. submitted an application under Rule 24b-2 requesting an extension of a previous grant of confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed on August 8, 2008.
Based on representations by NxStage Medical, Inc. that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit(s) will not be released to the public for the time period(s) specified:
Exhibit 10.43
through January 31, 2022
For the Commission, by the Division of Corporation Finance, pursuant to delegated authority:
Brent J. Fields
Secretary
Attachments
- Original document
- Permalink
Disclaimer
NxStage Medical Inc. published this content on 13 February 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 13 February 2019 14:31:10 UTC